Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-14-000265
Accepted
2014-01-31 00:15:11
Documents
1
Effectiveness Date
2014-01-30
Registration Form
F-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-14-000265.txt   1801
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: EFFECT | Act: 33 | File No.: 333-192783 | Film No.: 14562635
SIC: 2834 Pharmaceutical Preparations